Skip to main content
SpringerLink
Log in

Routine Postoperative Care After Liver Transplantation

  • Chapter
  • First Online:
Liver Anesthesiology and Critical Care Medicine

  • 2442 Accesses

Abstract

The liver transplant recipient is admitted to the intensive care unit (ICU) immediately after surgery for monitoring, resuscitation and stabilization of organ systems, management of intraoperative complications and hemodynamic pertubations, correction of coagulopathy, evaluation of graft function, and initiation of immunosuppression (Fig. 29.1). Physiological perturbations in the perioperative period affect the duration of ICU stay and may precipitate further complications and potentially multisystem organ failure (Fig. 29.2).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology. 2006;43(2 Suppl 1):S121–31.

    Article  PubMed  CAS  Google Scholar 

  2. Paugam-Burtz C, et al. Postreperfusion syndrome during liver transplantation for cirrhosis: outcome and predictors. Liver Transpl. 2009;15(5):522–9.

    Article  PubMed  Google Scholar 

  3. Zardi EM, et al. Cirrhotic cardiomyopathy. J Am Coll Cardiol. 2010;56(7):539–49.

    Article  PubMed  CAS  Google Scholar 

  4. Kim WR, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359(10):1018–26.

    Article  PubMed  CAS  Google Scholar 

  5. Hemprich U, Papadakos PJ, Lachmann B. Respiratory failure and hypoxemia in the cirrhotic patient including hepatopulmonary syndrome. Curr Opin Anaesthesiol. 2010;23(2):133–8.

    Article  PubMed  Google Scholar 

  6. Gines P, Schrier RW. Renal failure in cirrhosis. N Engl J Med. 2009;361(13):1279–90.

    Article  PubMed  CAS  Google Scholar 

  7. Bass NM, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010;362(12):1071–81.

    Article  PubMed  CAS  Google Scholar 

  8. Bernal W, et al. Acute liver failure. Lancet. 2010;376(9736):190–201.

    Article  PubMed  Google Scholar 

  9. Teperman LW, Peyregne VP. Considerations on the impact of hepatic encephalopathy treatments in the pretransplant setting. Transplantation. 2010;89(7):771–8.

    Article  PubMed  Google Scholar 

  10. Gines P, Guevara M. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Hepatology. 2008;48(3):1002–10.

    Article  PubMed  CAS  Google Scholar 

  11. Ammori JB, et al. Effect of intraoperative hyperglycemia during liver transplantation. J Surg Res. 2007;140(2):227–33.

    Article  PubMed  CAS  Google Scholar 

  12. Park C, et al. Severe intraoperative hyperglycemia is independently associated with surgical site infection after liver transplantation. Transplantation. 2009;87(7):1031–6.

    Article  PubMed  Google Scholar 

  13. Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood. 2010;116(6):878–85.

    Article  PubMed  CAS  Google Scholar 

  14. Senzolo M, et al. New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol. 2006;12(48):7725–36.

    PubMed  CAS  Google Scholar 

  15. Dabbagh O, et al. Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease. Chest. 2010;137(5):1145–9.

    Article  PubMed  Google Scholar 

  16. Dalmau A, Sabate A, Aparicio I. Hemostasis and coagulation monitoring and management during liver transplantation. Curr Opin Organ Transplant. 2009;14(3):286–90.

    Article  PubMed  Google Scholar 

  17. Apte NM, et al. Gastric colonization and pneumonia in intubated critically ill patients receiving stress ulcer prophylaxis: a randomized, controlled trial. Crit Care Med. 1992;20(5):590–3.

    Article  PubMed  CAS  Google Scholar 

  18. Sihler KC, Napolitano LM. Complications of massive transfusion. Chest. 2010;137(1):209–20.

    Article  PubMed  Google Scholar 

  19. Marik PE, Baram M, Vahid B. Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest. 2008;134(1):172–8.

    Article  PubMed  Google Scholar 

  20. Ramsay MA, et al. Controlled sedation with alphaxalone-alphadolone. Br Med J. 1974;2(5920):656–9.

    Article  PubMed  CAS  Google Scholar 

  21. Sessler CN, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166(10):1338–44.

    Article  PubMed  Google Scholar 

  22. Riker RR, Picard JT, Fraser GL. Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med. 1999;27(7):1325–9.

    Article  PubMed  CAS  Google Scholar 

  23. Hogg LH, et al. Interrater reliability of 2 sedation scales in a medical intensive care unit: a preliminary report. Am J Crit Care. 2001;10(2):79–83.

    PubMed  CAS  Google Scholar 

  24. De Jonghe B, et al. Adaptation to the Intensive Care Environment (ATICE): development and validation of a new sedation assessment instrument. Crit Care Med. 2003;31(9):2344–54.

    Article  PubMed  Google Scholar 

  25. Avripas MB, et al. Development of an intensive care unit bedside sedation scale. Ann Pharmacother. 2001;35(2):262–3.

    Article  PubMed  CAS  Google Scholar 

  26. Riker RR, Fraser GL. Altering intensive care sedation paradigms to improve patient outcomes. Crit Care Clin. 2009;25(3):527–38, viii–ix.

    Google Scholar 

  27. Breen D, et al. Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomised trial [ISRCTN47583497]. Crit Care. 2005;9(3):R200–10.

    Article  PubMed  Google Scholar 

  28. Dahaba AA, et al. Remifentanil versus morphine analgesia and sedation for mechanically ventilated critically ill patients: a randomized double blind study. Anesthesiology. 2004;101(3):640–6.

    Article  PubMed  CAS  Google Scholar 

  29. Muellejans B, et al. Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: a randomized, double-blind controlled trial [ISRCTN43755713]. Crit Care. 2004;8(1):R1–11.

    Article  PubMed  Google Scholar 

  30. Muellejans B, et al. Sedation in the intensive care unit with remifentanil/propofol versus midazolam/fentanyl: a randomised, open-label, pharmacoeconomic trial. Crit Care. 2006;10(3):R91.

    Article  PubMed  Google Scholar 

  31. Rozendaal FW, et al. Remifentanil-propofol analgo-sedation shortens duration of ventilation and length of ICU stay compared to a conventional regimen: a centre randomised, cross-over, open-label study in the Netherlands. Intensive Care Med. 2009;35(2):291–8.

    Article  PubMed  CAS  Google Scholar 

  32. Hall LG, Oyen LJ, Murray MJ. Analgesic agents. Pharmacology and application in critical care. Crit Care Clin. 2001;17(4):899–923, viii.

    Google Scholar 

  33. Lewis KS, et al. Effect of analgesic treatment on the physiological consequences of acute pain. Am J Hosp Pharm. 1994;51(12):1539–54.

    PubMed  CAS  Google Scholar 

  34. Devlin JW, Roberts RJ. Pharmacology of commonly used analgesics and sedatives in the ICU: benzodiazepines, propofol, and opioids. Crit Care Clin. 2009;25(3):431–49, vii.

    Google Scholar 

  35. Kelly DF, et al. Propofol in the treatment of moderate and severe head injury: a randomized, prospective double-blinded pilot trial. J Neurosurg. 1999;90(6):1042–52.

    Article  PubMed  CAS  Google Scholar 

  36. Pinaud M, et al. Effects of propofol on cerebral hemodynamics and metabolism in patients with brain trauma. Anesthesiology. 1990;73(3):404–9.

    Article  PubMed  CAS  Google Scholar 

  37. Hartung HJ. Intracranial pressure in patients with craniocerebral trauma after administration of propofol and thiopental. Anaesthesist. 1987;36(6):285–7.

    PubMed  CAS  Google Scholar 

  38. Hutchens MP, Memtsoudis S, Sadovnikoff N. Propofol for sedation in neuro-intensive care. Neurocrit Care. 2006;4(1):54–62.

    Article  PubMed  CAS  Google Scholar 

  39. Bennett SN, et al. Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med. 1995;333(3):147–54.

    Article  PubMed  CAS  Google Scholar 

  40. Henry B, Plante-Jenkins C, Ostrowska K. An outbreak of Serratia marcescens associated with the anesthetic agent propofol. Am J Infect Control. 2001;29(5):312–5.

    Article  PubMed  CAS  Google Scholar 

  41. Eddleston JM, Shelly MP. The effect on serum lipid concentrations of a prolonged infusion of propofol—hypertriglyceridaemia associated with propofol administration. Intensive Care Med. 1991;17(7):424–6.

    Article  PubMed  CAS  Google Scholar 

  42. Leisure GS, et al. Propofol and postoperative pancreatitis. Anesthesiology. 1996;84(1):224–7.

    Article  PubMed  CAS  Google Scholar 

  43. Casserly B, et al. Propofol infusion syndrome: an unusual cause of renal failure. Am J Kidney Dis. 2004;44(6):e98–101.

    Article  PubMed  Google Scholar 

  44. Vasile B, et al. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med. 2003;29(9):1417–25.

    Article  PubMed  Google Scholar 

  45. Venn RM, Hell J, Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care. 2000;4(5):302–8.

    Article  PubMed  CAS  Google Scholar 

  46. Nelson LE, et al. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology. 2003;98(2):428–36.

    Article  PubMed  CAS  Google Scholar 

  47. Shelly MP. Dexmedetomidine: a real innovation or more of the same? Br J Anaesth. 2001;87(5):677–8.

    Article  PubMed  CAS  Google Scholar 

  48. Venn RM, Grounds RM. Comparison between dexmedetomidine and propofol for sedation in the intensive care unit: patient and clinician perceptions. Br J Anaesth. 2001;87(5):684–90.

    Article  PubMed  CAS  Google Scholar 

  49. Zafirova Z, O’Connor M. Hepatic encephalopathy: current management strategies and treatment, including management and monitoring of cerebral edema and intracranial hypertension in fulminant hepatic failure. Curr Opin Anaesthesiol. 2010;23(2):121–7.

    Article  PubMed  Google Scholar 

  50. Finfer S, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–97.

    Article  PubMed  Google Scholar 

  51. Cook DJ, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med. 1994;330(6):377–81.

    Article  PubMed  CAS  Google Scholar 

  52. Vincent JL, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA. 1995;274(8):639–44.

    Article  PubMed  CAS  Google Scholar 

  53. Dubberke ER, et al. Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis. 2007;45(12):1543–9.

    Article  PubMed  Google Scholar 

  54. Herzig SJ, et al. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. JAMA. 2009;301(20):2120–8.

    Article  PubMed  CAS  Google Scholar 

  55. Lisman T, et al. Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol. 2010;53(2):362–71.

    Article  PubMed  Google Scholar 

  56. Warnaar N, Lisman T, Porte RJ. The two tales of coagulation in liver transplantation. Curr Opin Organ Transplant. 2008;13(3):298–303.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology, College of Physicians and Surgeons, Columbia University, 622 West 168 Street, New York, NY, 10032, USA

    Jonathan Hastie & Vivek K. Moitra

Authors
  1. Jonathan Hastie
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vivek K. Moitra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vivek K. Moitra .

Editor information

Editors and Affiliations

  1. , College of Physicians & Surgeons, Departments of Anesthesiology, of Columbia University, New York, 10032, New York, USA

    Gebhard Wagener

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media New York

About this chapter

Cite this chapter

Hastie, J., Moitra, V.K. (2012). Routine Postoperative Care After Liver Transplantation. In: Wagener, G. (eds) Liver Anesthesiology and Critical Care Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5167-9_29

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-5167-9_29

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-5166-2

  • Online ISBN: 978-1-4614-5167-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation